# Farmers & Merchants Bancorp Inc: overview

FMAO · Nasdaq · CIK 792966 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmao.md) · [Financials](/companies/fmao/financials.md) · [Filings](/companies/fmao/filings.md) · [Insiders](/companies/fmao/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.48](/filings/0001193125-26-081475.md) | [0.61](/filings/0001193125-26-081475.md) | [0.51](/filings/0001193125-26-190726.md) | [0.56](/filings/0001193125-26-323955.md) | [0.64](/filings/0001193125-26-081475.md) | [0.71](/filings/0001193125-26-081475.md) | [0.70](/filings/0001193125-26-190726.md) | [0.86](/filings/0001193125-26-323955.md) |
| Free cash flow | $m | [18.3 d](/filings/0001193125-25-260124.md) | [1.9 d](/filings/0001193125-26-081475.md) | [10.6](/filings/0001193125-26-190726.md) | [0.4 d](/filings/0001193125-26-323955.md) | [10.7 d](/filings/0001193125-25-260124.md) | [13.2 d](/filings/0001193125-26-081475.md) | [7.0](/filings/0001193125-26-190726.md) | [10.6 d](/filings/0001193125-26-323955.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.01](/filings/0000950170-24-021373.md) | [2.46](/filings/0000950170-25-027602.md) | [1.67](/filings/0001193125-26-081475.md) | [1.90](/filings/0001193125-26-081475.md) | [2.43](/filings/0001193125-26-081475.md) |
| Free cash flow | $m | [32.8](/filings/0000950170-24-021373.md) | [38.1](/filings/0000950170-25-027602.md) | [11.2](/filings/0001193125-26-081475.md) | [30.6](/filings/0001193125-26-081475.md) | [35.0](/filings/0001193125-26-081475.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmao/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $33.2m | 1,087,009 |  | Added +163,682 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.7m | 577,302 |  | Added +42,564 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.2m | 334,406 |  | Added +25,199 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $8.8m | 289,178 |  | Reduced −1,442 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.2m | 268,387 |  | Added +41,470 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $8.2m | 268,035 |  | Added +43,697 |
| [Goelzer Investment Management, Inc.](/funds/1550057.md) | 2026-06-30 | $6.8m | 223,604 |  | Reduced −105,000 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $5.7m | 186,959 |  | Added +125,458 |
| [Mendel Money Management](/funds/1600585.md) | 2026-06-30 | $3.5m | 115,877 |  | Reduced −7,201 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $3.3m | 106,346 |  | Added +11,410 |

## Recent filings

[All 735 filings](/companies/fmao/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:52 ET | [8-K](/filings/0001193125-26-429065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-429065 |
| 2026-07-29 | 16:39 ET | [10-Q](/filings/0001193125-26-323955.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323955 |
| 2026-07-27 | 16:45 ET | [8-K](/filings/0001193125-26-318198.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318198 |
| 2026-07-07 | 15:19 ET | [8-K](/filings/0001193125-26-297378.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-297378 |
| 2026-04-29 | 13:52 ET | [10-Q](/filings/0001193125-26-190726.md) | Quarterly report, period 2026-03-31 | 0001193125-26-190726 |
| 2026-04-22 | 16:47 ET | [8-K](/filings/0001193125-26-170660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-170660 |
| 2026-04-21 | 16:45 ET | [8-K](/filings/0001193125-26-167045.md) | 5.07 Shareholder vote results | 0001193125-26-167045 |
| 2026-03-24 | 17:00 ET | [DEF 14A](/filings/0001140361-26-010915.md) | Proxy statement, period 2026-04-20 | 0001140361-26-010915 |
| 2026-02-27 | 13:09 ET | [10-K](/filings/0001193125-26-081475.md) | Annual report, period 2025-12-31 | 0001193125-26-081475 |
| 2026-02-12 | 16:45 ET | [8-K](/filings/0001193125-26-048918.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-048918 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-081475.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 792966
- Tickers: FMAO
- Exchange: Nasdaq
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: OH
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 13:43 ET. No prices; not investment advice.